LAZZARI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 72
EU - Europa 55
AS - Asia 16
Totale 143
Nazione #
US - Stati Uniti d'America 72
SE - Svezia 37
IT - Italia 14
IN - India 7
CN - Cina 6
FI - Finlandia 2
JP - Giappone 2
DE - Germania 1
IL - Israele 1
NL - Olanda 1
Totale 143
Città #
Ashburn 15
Lawrence 8
New York 8
Princeton 7
Pune 7
Rome 7
Shanghai 6
Los Angeles 3
Milan 3
Florence 2
Harwich 2
Helsinki 2
Honcho 2
Berlin 1
Borås 1
Giv‘atayim 1
Washington 1
Totale 76
Nome #
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 32
Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors 23
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 20
Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma 16
Metabolism and immune modulation in patients with solid tumors: Systematic review of preclinical and clinical evidence 16
Angiogenesis inhibition in lung cancer: Emerging novel strategies 16
Intratumoral cellular heterogeneity: Implications for drug resistance in patients with non-small cell lung cancer 13
Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic 12
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 8
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 1
Totale 157
Categoria #
all - tutte 1.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 3 1 1
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202211 1 0 2 4 0 0 0 1 1 0 1 1
2022/202358 18 14 4 0 1 6 1 10 0 0 2 2
2023/202482 5 10 12 8 7 25 5 5 0 3 2 0
Totale 157